Skip to main content

Your search for “Melanoma” returned 47 results

UC San Diego Bruce Gorder 5K Walk For Melanoma Celebrates 20 Years on Oct. 19

September 23, 2013

By the time Bruce Gorder was diagnosed with melanoma, it was too late. At just 37, his life was taken by the deadly disease, leaving his wife, young daughter and family devastated. Yet out of the tragedy a new initiative was borne—one that could potentially save lives.

UC San Diego Health First in Region to Provide Novel Therapy for Melanoma

June 4, 2024

Breakthrough one-time cancer treatment option for select patients with metastatic melanoma and solid tumors now offered at UC San Diego Health.

UC San Diego Gorder Walk Raises Funds for Melanoma Research Oct. 6

October 3, 2012

Briana Bilbray is only 25, yet she is undergoing the fight of her life—against melanoma. In addition to waging a battle against the disease, Briana is also working to raise awareness of the risks of melanoma, particularly among young people.

Gorder Walk 5K to Promote Melanoma Awareness on October 11

October 2, 2014

…and dangerous role of melanoma. In 1993, he launched the Bruce Gorder 5K UC San Diego Walk for Melanoma in honor of his late son who lost a seven-year battle with the deadly skin cancer at age 37. Today, it is still the only 5K dedicated to raising funds for…

Gorder Walk Raises Funds for Melanoma Research at UC San Diego Moores Cancer Center Sept. 24

September 19, 2011

…host the 18th annual Bruce Gorder 5K Walk for Melanoma Sept. 24 on the university campus. The event brings the community together to raise funds for melanoma research at the UC San Diego Moores Cancer Center, as well as build awareness for prevention and early detection of the disease.

Melanoma of the Eye Caused by Two Gene Mutations

May 29, 2014

Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.

New At-Risk Group Identified for Gastrointestinal Stromal Tumors

October 7, 2014

Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine. One key finding: Patients of Asian descent, who have not previously been identified…

Nanoengineers Receive $4.3M From NIH To Continue Studies Using Plant Viruses To Treat Cancer

October 17, 2022

Researchers led by Nicole Steinmetz, professor of nanoengineering at the University of California San Diego, have received $4.3 million in grants from the National Institutes of Health (NIH) to advance their research using plant viruses to develop cancer immunotherapies.

Beneficial Skin Bacteria Protect Against Skin Cancer

February 28, 2018

Science continues to peel away layers of the skin microbiome to reveal its protective properties. In a study published in Science Advances on February 28, University of California San Diego School of Medicine researchers report a potential new role for some bacteria on the skin: protecting against cancer.

Plant Virus Plus Immune Cell-Activating Antibody Clear Colon Cancer in Mice, Prevent Recurrence

June 21, 2022

A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by UC San Diego researchers. In mouse models of colon cancer, the therapy eliminated all tumors and prevented their recurrence.

Category navigation with Social links